VRX
VALEANT PHARMACEUTICALS INTLData as of 2018 Q2 (06-30) · 13F snapshot
Summary
VALEANT PHARMACEUTICALS INTL (VRX) is held by 9 tracked hedge-fund managers, a combined reported value of ~$824.07M; the largest are Bill Ackman, Philippe Laffont, Renaissance Technologies. 4 members of Congress have disclosed STOCK Act trades. Data as of 2018 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Quiet
Gurus holding9
Congress trades4
Price—no price
Sectors0
This quarter's moves
Top holderBill AckmanNew0
Added0
Trimmed / sold0
Bill AckmanTrim
Value $263.02M4.4% of portfolio18,114,4322016 Q4
Philippe LaffontNew large stake
Value $170.06M1.7% of portfolio1,673,0072015 Q4
Value $70.71M— of portfolio3,042,5002018 Q2
Value $50.16M— of portfolio3,500,0002017 Q3
Value $35.53M— of portfolio1,528,9002018 Q2
Dan LoebNew
Value $32.96M0.5% of portfolio250,0002014 Q1
Value $24.85M— of portfolio945,0002016 Q1
Value $19.17M— of portfolio1,320,0002016 Q4
Value $7.62M— of portfolio75,0002015 Q4
Value $2.46M— of portfolio100,0002016 Q3
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Bill Ackman | $263.02M | 4.4% | Trim |
| Philippe Laffont | $170.06M | 1.7% | New large stake |
| Ken GriffinPUT | $70.71M | — | — |
| Steven CohenPUT | $50.16M | — | — |
| Ken GriffinCALL | $35.53M | — | — |
| Dan Loeb | $32.96M | 0.5% | New |
| David Tepper | $24.85M | — | — |
| Steven CohenCALL | $19.17M | — | — |
| Izzy EnglanderPUT | $7.62M | — | — |
| Izzy EnglanderCALL | $2.46M | — | — |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.